|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Excess tax benefit from stock-based compensation | |||||
| Gain on sale of patent assets, net | |||||
| Amortization of premium and discount on investments | |||||
| Deferred taxes | |||||
| Unrealized foreign currency (gain) loss | |||||
| Fair value adjustments on deferred payment obligations | |||||
| Gain on extinguishment of deferred payment obligation | |||||
| Impairment losses | |||||
| Realized loss on exchange of short-term investments | |||||
| Other | |||||
| Changes in assets and liabilities, net of business acquired: | |||||
| Accounts receivable | |||||
| Other receivables | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued and other liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Sales of investments | |||||
| Decrease in restricted cash | |||||
| Purchases of property and equipment | |||||
| Acquisitions of patent assets | |||||
| Deposit for acquisition of patent assets | |||||
| Proceeds from sale of patent assets | |||||
| Acquisition of other assets | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Repayments of principal on deferred payment obligations | |||||
| Proceeds from deferred payment obligations | |||||
| Proceeds from issuance of term debt | |||||
| Payment of debt issuance costs | |||||
| Repayment of principal on term debt | |||||
| Deferred acquisition payment | |||||
| Proceeds from exercise of stock options | |||||
| Taxes paid related to net-share settlements of restricted stock units | |||||
| Excess tax benefit from stock-based compensation | |||||
| Payments of capital leases | |||||
| Payments of Dividends | |||||
| Repurchase of common stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Foreign-currency effect on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Non-cash investing and financing activities | |||||
| Change in patent assets purchased and accrued but not paid | |||||
| Change in fixed assets purchased and accrued but not paid | |||||
| Change in other assets purchased and accrued but not paid | |||||
| Patent assets and intangible assets received in barter transactions | |||||
| Nonmonetary exchange for investments | |||||
| Issuance of common stock related to business acquisition | |||||
| Unpaid cash consideration for business acquisition | |||||
Loading...